How do we interpret the results of the Breast Cancer Prevention trial?
Margolese
R G
RG
D018931:Antineoplastic Agents, Hormonal / Q000191:economics / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000517:prevention & control*; D002986:Clinical Trials as Topic; D003362:Cost-Benefit Analysis; D005260:Female; D006801:Humans; D015994:Incidence; D011322:Primary Prevention / Q000379:methods*; D013629:Tamoxifen / Q000191:economics / Q000627:therapeutic use*
D018931:Antineoplastic Agents, Hormonal; D013629:Tamoxifen